Equity - Summary of the Warrants (Parenthetical) (Details) - $ / shares		Dec. 31, 2023	Apr. 10, 2023
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)			$ 7.5
Dragasac Warrant
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)	[1]	$ 67.7
Dragasac Warrant | Class A Common Stock
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)		$ 67.7
Warrants per share, percentage		80.00%
Public Warrants
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)	[2]	$ 115
Warrants outstanding		14,374,478
Public Warrants | Class A Common Stock
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)		$ 115
Sponsor Warrants
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)	[2]	$ 115
Warrants outstanding		8,499,999
Sponsor Warrants | Class A Common Stock
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)		$ 115

[1] The exercise price is the lesser of $67.70 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.

[2] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.